Literature DB >> 12541362

[Study of the relation between MMP2, MMP9 and nasopharyngeal carcinoma].

X Zhang1, Y Guo, Q Ye, Z Yang, Z Dong.   

Abstract

OBJECTIVE: To evaluate the role of matrix metalloproteinase (MMP) in the invasion and metastasis of nasopharyngeal carcinoma (NPC).
METHOD: Twenty-six cases of NPC were studied by immunohistochmical method using monocolonal antibody to MMP2 and MMP9. RESULT: It was showed that there were significantly correlation between MMP2 or MMP9 and the invasion and metastasis of NPC. The positive rate of MMP2 and MMP9 were higher in NPC with cervical lymph node involvement than that of no cervical lymph node involvement. And they were lower in well differentiated NPC than poorly differentiated NPC.
CONCLUSION: The results indicate that MMP2 and MMP9 may play a critical role in assisting carcinoma cell to degrade basement membrane to invade surrounding tissues and to form metastatic colonies in lymph nodes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 12541362

Source DB:  PubMed          Journal:  Lin Chuang Er Bi Yan Hou Ke Za Zhi


  3 in total

1.  Expression of matrix metalloproteinase 9 in nasopharyngeal carcinoma and association with Epstein-Barr virus infection.

Authors:  Jian-Guo Tang; Xuan Li; Ping Chen
Journal:  J Zhejiang Univ Sci       Date:  2004-10

2.  EGCG inhibits proliferation, invasiveness and tumor growth by up-regulation of adhesion molecules, suppression of gelatinases activity, and induction of apoptosis in nasopharyngeal carcinoma cells.

Authors:  Chih-Yeu Fang; Chung-Chun Wu; Hui-Yu Hsu; Hsin-Ying Chuang; Sheng-Yen Huang; Ching-Hwa Tsai; Yao Chang; George Sai-Wah Tsao; Chi-Long Chen; Jen-Yang Chen
Journal:  Int J Mol Sci       Date:  2015-01-23       Impact factor: 5.923

3.  Assessment and clinicopathological correlation of matrix metalloproteinase 9 expression in nasopharyngeal carcinoma.

Authors:  Ashok Kumar Das; Nizara Baishya; Anupam Sarma; Amal Chandra Kataki; Avdesh Kumar Rai; Chandi Ram Kalita
Journal:  J Carcinog       Date:  2019-05-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.